Europe Conjugate Vaccine Market:
Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached with a protein to enhance immunogenicity and protect against invasive diseases. Europe is a market with stable growth for conjugate vaccines. The conjugate vaccine market in Europe is expected to expand at a CAGR of 3.6% leading to a revenue of USD 8.94 Bn by 2023. By volume, it is anticipated to reach 504.46 Million units by 2023, expanding at a CAGR of 3.7%.
The U.K. was the first country to introduce MenB-4C into their National Infant Immunization Program (2015). In all EU/EEA countries, Hib vaccination has been part of the immunization programs, since 2010, and high coverage has been sustained.
Market Segmentation:
o Based on disease indication, the market is segmented into pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal and others.
o Based on end user, the market is segmented into pediatric and adult.
o Based on countries, the Europe market is divided into EU5 and Rest of EU.
Key growth factors:
The European market will not display any extraordinary growth but average figures. Key growth factors include increasing emphasis on and availability of funds for research and development. Moreover, advancements in medical science, awareness about the availability of a higher number of vaccines for diseases will drive the growth of this market. Increasing vaccination programs by government, their initiatives, and increase in research and development activities will result in the growth of this market.
Threats and key players:
o The Europe conjugate vaccine market is expected to grow at a steady pace. The scope for significant growth is limited. Vaccine shortages are a major problem which will hinder the growth of the market. The shortage of vaccines affecting some EU/EEA Member States had direct effects on the delivery of national vaccination programmes. Since 2015, nine EU/EEA member states had to adjust their immunization policies.
o Major conjugate vaccine providers operating in the market are GlaxoSmithKline, Pfizer Inc., Merck, Novartis, Sanofi Pasteur, etc.
What's covered in the report?
1. Overview of the Europe conjugate vaccine market
2. Market drivers and challenges in the Europe conjugate vaccine market
3. Market trends in the Europe conjugate vaccine market
4. Historical, current and forecasted market size data for Europe based on disease indication (pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal conjugate vaccines) - by revenue and by volume
5. Historical, current and forecasted market size data for Europe based on end user (pediatric and adult conjugate vaccines) - by revenue and by volume
6. Historical, current and forecasted market size data of conjugate vaccines based on countries (EU5, Rest of EU) - by revenue and by volume
7. Historical, current and forecasted market size data for country-wise segments - by revenue and by volume
8. Analysis of the competitive landscape and profiles of major companies operating in the European market
Why buy?
o Understand the demand for conjugate vaccines to determine the viability of the market
o Understand the country-specific market size and observations for each segment
o Develop strategies based on the drivers, trends and highlights for each of the segments
o Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed
o Recognize the key competitors of this market and respond accordingly
o Identify the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth
o Define the competitive positioning by comparing the products and services with the key players in the market
Customizations available
With the given market data, Netscribes offers customizations according to specific needs. Write to us at support@researchonglobalmarkets.com.
| Price : US$ 3380 | Date : Oct 2024 |
| Category : Chemicals and Materials | Pages : 199 |
| Price : US$ 3595 | Date : Oct 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 183 |
| Price : US$ 3450 | Date : Oct 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 196 |
| Price : US$ 3590 | Date : Oct 2024 |
| Category : Consumer Goods and Retail | Pages : 179 |
| Price : US$ 3650 | Date : Oct 2024 |
| Category : Consumer Goods and Retail | Pages : 176 |
We will be happy to help you find what you need. Please call us or write to us:
Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).
This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection
Request Sample 
Request Discount 
Inquire Before Buy
